Disease Info Card

Atrophy Of Breast

Information about Atrophy Of Breast: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Atrophy Of Breast

Most recent studies have shown that Atrophy Of Breast shares some biological mechanisms with atrophy, becker-nevus, breast-diseases, breast-fibrocystic-disease, carcinoma, cicatrix, congenital-abnormality, congenital-funnel-chest, hamartoma, hematoma, hypertrichosis, hypoplasia, malignant-neoplasm-of-breast, malignant-neoplasms, mammary-neoplasms, melanocytic-nevus, neoplasms, pain, poland-syndrome, skin-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Atrophy Of Breast, and have been seen in publications frequently: Cell Adhesion, Cell Cycle, Cell Migration, Cell Proliferation, Embryo Development, Gland Development, Insemination, Keratinization, Lactation, Mammary Gland Development, Mating, Menopause, Pathogenesis, Pigmentation, Senescence, Stem Cell Proliferation, Thelarche, Tooth Eruption, Translation, Transposition

Quite a number of genes have been found to play important roles in Atrophy Of Breast, such as CDK2AP2, CDKN2A, FMN1, LAMTOR2, LHX2, PCNA, PRL, PRM1, RPLP1, RPP14, S100A9, SLC25A15, SUB1, TBX3, TFF2, TP63. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.